# Enterprise AI Governance Policy

**[Organization Name]**

**Version 1.1**

**[Effective Date]**

---

| Field | Value |
|-------|-------|
| Document Owner | [Chief Information Security Officer / Chief AI Officer] |
| Effective Date | [Effective Date] |
| Review Cycle | Annual or upon significant regulatory/technological change |
| Classification | Internal / Confidential |

---

## Table of Contents

1. Purpose and Scope
2. AI Governance Principles
3. Governance Structure and Accountability
4. AI Risk Classification
5. AI Lifecycle Governance
6. Acceptable Use of AI
7. Third-Party AI Requirements
8. AI Incident Management
9. Training and Awareness
10. Policy Compliance and Exceptions
11. Document Control

---

## 1. Purpose and Scope

### 1.1 Purpose

This policy establishes the governance framework for the responsible development, deployment, and use of artificial intelligence (AI) systems across [Organization Name]. It provides the foundational principles, accountability structures, and oversight mechanisms necessary to ensure AI initiatives align with organizational objectives while maintaining appropriate risk controls, ethical standards, and regulatory compliance.

This policy serves as the authoritative reference for all AI-related activities and establishes the basis for subordinate standards, procedures, and technical controls that together comprise the enterprise AI governance program. *For practical implementation guidance, refer to the AI Implementation Playbook.*

### 1.2 Scope

This policy applies to all AI systems developed, acquired, deployed, or operated by [Organization Name], regardless of whether the system is built internally, procured from third parties, or accessed via cloud services. Coverage includes:

- Machine learning models (supervised, unsupervised, and reinforcement learning)
- Large language models (LLMs) and generative AI systems
- Natural language processing (NLP) and computer vision systems
- AI-enabled decision support and automation systems
- Third-party AI services integrated into organizational workflows
- AI components embedded in enterprise applications and platforms

This policy applies to all workforce members, including employees, contractors, consultants, and third parties who develop, deploy, operate, or use AI systems on behalf of the organization.

### 1.3 Regulatory and Framework Alignment

This governance framework is designed to align with recognized AI governance standards and regulatory requirements, including:

- **NIST AI Risk Management Framework (AI RMF 1.0)** – Primary governance structure
- **ISO/IEC 42001:2023** – AI Management System requirements
- **HIPAA Security Rule** – For AI systems processing protected health information
- **OWASP Top 10 for LLM Applications** – Technical security controls
- **EU AI Act Risk Classification Model** – Risk categorization methodology (for future-readiness)

---

## 2. AI Governance Principles

All AI initiatives shall be guided by the following foundational principles, which establish the ethical and operational standards for trustworthy AI:

### 2.1 Patient Safety and Clinical Validity

AI systems used in clinical or patient care contexts must demonstrate clinical validity appropriate to their intended use and must include safeguards to prevent harm to patients. AI-assisted clinical decisions shall maintain physician oversight and shall not replace clinical judgment without explicit validation and approval.

### 2.2 Transparency and Explainability

AI systems must provide appropriate levels of transparency regarding their capabilities, limitations, and decision-making processes. Users shall be informed when they are interacting with AI systems, and explanations of AI-generated outputs shall be available commensurate with the risk level and use case.

### 2.3 Fairness and Non-Discrimination

AI systems shall be designed, tested, and monitored to identify and mitigate bias that could result in discriminatory outcomes. This includes bias in training data, algorithmic design, and deployment contexts, with particular attention to protected classes and vulnerable populations.

### 2.4 Privacy and Data Protection

AI systems shall comply with all applicable privacy regulations and organizational data protection policies. Data minimization principles shall guide the collection and use of data for AI purposes, and appropriate safeguards shall protect sensitive information throughout the AI lifecycle.

### 2.5 Security and Resilience

AI systems shall incorporate security controls appropriate to their risk classification, including protection against adversarial attacks, data poisoning, prompt injection, and unauthorized access. Systems shall be designed for resilience, with appropriate fallback mechanisms and human override capabilities.

### 2.6 Accountability and Human Oversight

Clear accountability shall be established for all AI systems, with designated owners responsible for system performance, compliance, and risk management. Human oversight mechanisms shall be implemented proportionate to the risk level, ensuring that humans retain the ability to intervene, override, or discontinue AI systems as necessary.

### 2.7 Continuous Improvement

AI governance practices shall be subject to ongoing evaluation and improvement. Lessons learned from incidents, near-misses, and emerging best practices shall inform updates to policies, procedures, and technical controls.

---

## 3. Governance Structure and Accountability

### 3.1 AI Governance Board

An AI Governance Board shall be established with authority to oversee AI strategy, approve HIGH risk AI deployments, and ensure alignment with organizational objectives and risk tolerance. The Board shall include representation from:

- Executive Leadership (CEO/COO or designee)
- Chief Information Officer (CIO)
- Chief Information Security Officer (CISO)
- Chief Medical Officer (CMO) or Clinical Leadership
- Chief Compliance Officer / Privacy Officer
- General Counsel / Legal
- Data Science / AI Technical Leadership

### 3.2 Roles and Responsibilities

#### 3.2.1 AI System Owner

Each AI system shall have a designated System Owner accountable for:

- Ensuring the system operates within approved parameters and intended use
- Maintaining current risk assessments and documentation
- Reporting performance metrics and incidents to appropriate governance bodies
- Coordinating with security, compliance, and clinical stakeholders

#### 3.2.2 AI Development Teams

Teams developing AI systems are responsible for:

- Implementing security and privacy controls during development
- Conducting bias testing and validation appropriate to the use case
- Documenting model architecture, training data, and performance characteristics
- Participating in risk assessments and security reviews

#### 3.2.3 Information Security

The Information Security function is responsible for:

- Defining and maintaining AI-specific security controls
- Conducting security assessments of AI systems
- Monitoring for AI-specific threats and vulnerabilities
- Incident response for AI-related security events

#### 3.2.4 Compliance and Privacy

Compliance and Privacy functions are responsible for:

- Ensuring AI systems comply with applicable regulations (HIPAA, state privacy laws)
- Conducting privacy impact assessments for AI systems processing personal data
- Advising on data use agreements and consent requirements
- Monitoring regulatory developments affecting AI governance

---

## 4. AI Risk Classification

All AI systems shall be classified according to their potential impact on patient safety, operational criticality, and regulatory exposure. Risk classification determines the level of governance oversight, documentation requirements, and control rigor applied throughout the AI lifecycle.

*Detailed risk assessment methodology, including factor definitions, scoring calculations, and worked examples, is provided in the AI Risk Assessment Framework.*

### 4.1 Risk Tier Definitions

| Risk Tier | Characteristics | Examples |
|-----------|-----------------|----------|
| **HIGH** | Direct impact on patient safety, clinical decisions, or outcomes; autonomous decision-making; processing of sensitive health information at scale | Clinical decision support with autonomous recommendations; diagnostic AI; treatment planning systems; patient risk stratification |
| **MODERATE** | Indirect clinical impact; significant operational dependency; processing of PHI with human review; workforce-affecting decisions | Clinical documentation assistance; scheduling optimization; revenue cycle analytics; workforce scheduling; prior authorization automation |
| **LOW** | Administrative functions; no direct patient impact; limited PHI exposure; human-in-the-loop required for all decisions | Meeting transcription; document summarization; internal chatbots; IT helpdesk automation; facility management optimization |

### 4.2 Risk Assessment Process

Prior to deployment, all AI systems shall undergo a formal risk assessment that evaluates:

- **Intended Use and Context:** The specific purpose, user population, and operational context in which the AI system will be deployed.
- **Data Sensitivity:** The types and volume of data processed, including PHI, PII, and other sensitive information categories.
- **Autonomy Level:** The degree to which the system operates independently versus requiring human oversight or approval.
- **Impact Potential:** The potential consequences of system errors, including patient harm, operational disruption, financial loss, or reputational damage.
- **Reversibility:** Whether decisions or actions taken by the AI system can be reversed or corrected.
- **Regulatory Exposure:** Applicable regulatory requirements and the consequences of non-compliance.

*For step-by-step guidance on conducting risk assessments, refer to the AI Implementation Playbook, Section 3: Risk Assessment Execution Guide.*

---

## 5. AI Lifecycle Governance

Governance controls shall be applied throughout the AI system lifecycle, from initial conception through retirement. The following requirements establish minimum governance expectations for each lifecycle phase.

### 5.1 Planning and Design

- Business case documentation including intended use, expected benefits, and success criteria
- Preliminary risk classification and identification of applicable controls
- Stakeholder identification and engagement plan
- Data requirements and availability assessment
- Privacy impact assessment for systems processing personal data

### 5.2 Development and Training

- Training data governance including provenance documentation, quality validation, and bias assessment
- Model architecture documentation and version control
- Security controls integrated into development pipelines (DevSecOps)
- Secure development environment with appropriate access controls
- Code review and security testing requirements

### 5.3 Validation and Testing

- Performance validation against defined accuracy, precision, and recall thresholds
- Bias and fairness testing across relevant demographic groups
- Security testing including adversarial robustness assessment
- Clinical validation for patient-care applications (as appropriate)
- User acceptance testing with representative end users

### 5.4 Deployment Approval

Prior to production deployment, AI systems shall receive formal approval through the following process:

| Risk Tier | Approval Authority |
|-----------|-------------------|
| **LOW** | System Owner approval with notification to AI Governance Board |
| **MODERATE** | Security and Compliance review with System Owner and CISO approval |
| **HIGH** | Full AI Governance Board review and approval required |

*For detailed approval workflow procedures, refer to the AI Implementation Playbook, Section 5: Approval Workflow Procedures.*

### 5.5 Operations and Monitoring

- Continuous performance monitoring against established baselines
- Model drift detection and alerting
- Security monitoring for AI-specific threats
- User feedback collection and analysis
- Periodic re-validation and bias reassessment
- Audit logging and retention per regulatory requirements

### 5.6 Maintenance and Updates

- Change management process for model updates and retraining
- Re-assessment of risk classification when significant changes occur
- Documentation updates to reflect current system state
- Regression testing requirements for updates

### 5.7 Retirement and Decommissioning

- Formal retirement process with stakeholder notification
- Secure disposition of models, training data, and associated artifacts
- Documentation archival per retention requirements
- Transition planning for dependent systems and processes

---

## 6. Acceptable Use of AI

### 6.1 Permitted Uses

AI systems may be used for purposes that:

- Align with the organization's mission and strategic objectives
- Have been approved through the appropriate governance process
- Comply with applicable laws, regulations, and organizational policies
- Include appropriate human oversight mechanisms
- Do not conflict with patient rights or organizational values

### 6.2 Prohibited Uses

The following uses of AI are prohibited without explicit exception approval from the AI Governance Board:

- Fully autonomous clinical decision-making without physician oversight
- Processing of organizational data through unapproved third-party AI services
- Use of AI to make employment decisions without human review
- Deploying AI systems that have not completed the required risk assessment and approval process
- Using patient data for AI training without appropriate consent and privacy protections
- Creating synthetic patient data that could be used to re-identify individuals
- Surveillance or monitoring that violates employee or patient privacy expectations

### 6.3 Shadow AI Prevention

Workforce members shall not deploy or use AI systems, including publicly available generative AI services, to process organizational data without explicit approval. Departments suspecting or discovering unauthorized AI use shall report it through established security incident channels.

*For shadow AI identification methods and remediation procedures, refer to the AI Implementation Playbook, Section 2.3: Shadow AI Identification.*

---

## 7. Third-Party AI Requirements

AI systems or components obtained from third parties shall be subject to the same governance requirements as internally developed systems, with additional vendor management controls.

### 7.1 Vendor Assessment

Prior to procurement, third-party AI vendors shall be assessed for:

- Security posture and certifications (SOC 2, ISO 27001, HITRUST)
- AI governance practices and model documentation
- Bias testing and fairness validation methodologies
- Data handling practices and privacy compliance
- Incident response and notification capabilities
- Business continuity and service level commitments

*Detailed vendor assessment procedures and questionnaire templates are provided in the AI Implementation Playbook, Section 6: Third-Party AI Procurement Guide.*

### 7.2 Contractual Requirements

Contracts with AI vendors shall include provisions addressing:

- Data ownership and use restrictions (particularly regarding training data)
- Transparency and explainability requirements
- Security incident notification timelines
- Audit rights and compliance verification
- Model update notification and approval requirements
- Liability and indemnification for AI-related harms
- Exit and data portability provisions

---

## 8. AI Incident Management

### 8.1 Incident Definition

An AI incident is any event involving an AI system that results in, or has the potential to result in:

- Patient harm or adverse clinical outcomes
- Unauthorized access to or disclosure of sensitive information
- Significant operational disruption
- Biased or discriminatory outcomes
- Regulatory non-compliance
- Reputational harm to the organization

### 8.2 Response Requirements

- AI incidents shall be reported through established incident management channels immediately upon detection
- Containment procedures shall include the ability to immediately disable or bypass AI system outputs
- Root cause analysis shall address both technical and governance failures
- Lessons learned shall be incorporated into governance improvements

*Detailed incident response procedures, severity classifications, and communication templates are provided in the AI Implementation Playbook, Section 10: AI Incident Response Playbook.*

---

## 9. Training and Awareness

### 9.1 General AI Literacy

All workforce members shall receive baseline AI literacy training covering the organization's AI governance principles, acceptable use requirements, and mechanisms for reporting concerns about AI systems.

### 9.2 Role-Based Training

Additional training shall be provided based on role:

| Role | Training Focus |
|------|----------------|
| AI Developers | Secure AI development practices, bias mitigation techniques, documentation requirements |
| AI System Users | System capabilities and limitations, appropriate reliance, escalation procedures |
| Clinical Staff | Clinical AI system validation, maintaining professional judgment, patient communication |
| Leadership | AI governance responsibilities, risk management, strategic oversight |

---

## 10. Policy Compliance and Exceptions

### 10.1 Compliance Monitoring

Compliance with this policy shall be monitored through:

- Periodic audits of AI system inventory and documentation
- Review of risk assessments and control implementations
- Monitoring of AI-related incidents and near-misses
- Assessment of training completion rates

### 10.2 Non-Compliance

Violations of this policy may result in:

- Immediate suspension of AI system operations
- Disciplinary action in accordance with HR policies
- Required remediation and re-assessment
- Escalation to AI Governance Board and executive leadership

### 10.3 Exception Process

Exceptions to this policy require:

- Written justification documenting business need and risk mitigation measures
- Approval by CISO for MODERATE risk exceptions
- Approval by AI Governance Board for HIGH risk exceptions
- Time-limited duration with scheduled reassessment
- Documentation in the AI system's governance record

---

## 11. Document Control

### 11.1 Version History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | [Date] | [Author] | Initial release |
| 1.1 | [Date] | [Author] | Added cross-references to subordinate documents; standardized risk tier terminology |

### 11.2 Related Documents

The following subordinate documents support implementation of this policy:

| Document | Purpose |
|----------|---------|
| **AI Risk Assessment Framework** | Establishes methodology for risk classification, including factor definitions, scoring calculations, and tier assignment |
| **AI Security Controls Catalog** | Defines 50 security and governance controls across six domains (GOV, DATA, MODEL, OPS, SUPPLY, LLM) with risk-tier applicability |
| **AI System Documentation Standards** | Specifies documentation requirements throughout the AI lifecycle, including model cards, data documentation, validation reports, and operational runbooks |
| **AI Implementation Playbook** | Provides step-by-step execution guidance for all governance activities, including intake procedures, risk assessment execution, control implementation, approval workflows, vendor assessment, LLM deployment, clinical AI implementation, monitoring operations, and incident response |

### 11.3 Document Relationships

```
┌─────────────────────────────────────────────────────────────┐
│           ENTERPRISE AI GOVERNANCE POLICY                    │
│                   (This Document)                            │
│              Establishes WHAT is required                    │
└─────────────────────────┬───────────────────────────────────┘
                          │
          ┌───────────────┼───────────────┬───────────────┐
          ▼               ▼               ▼               ▼
   ┌─────────────┐ ┌─────────────┐ ┌─────────────┐ ┌─────────────┐
   │ AI Risk     │ │ AI Security │ │ AI System   │ │ AI          │
   │ Assessment  │ │ Controls    │ │ Document-   │ │ Implement-  │
   │ Framework   │ │ Catalog     │ │ ation Stds  │ │ ation       │
   │             │ │             │ │             │ │ Playbook    │
   │ HOW to      │ │ WHAT        │ │ WHAT to     │ │ HOW TO do   │
   │ assess risk │ │ controls    │ │ document    │ │ everything  │
   └─────────────┘ └─────────────┘ └─────────────┘ └─────────────┘
```

### 11.4 Review and Approval

| Role | Name | Date |
|------|------|------|
| Document Owner | [CISO Name] | [Date] |
| AI Governance Board Chair | [Name] | [Date] |
| Legal Review | [Name] | [Date] |
| CMO Approval (Clinical Content) | [Name] | [Date] |

---
